InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by O'Byrne Jason. Officer active across 1 company, notably Vir Biotechnology, Inc.. Aggregated, 4 disclosures have been published. History available since 21 August 2026. The latest transaction was disclosed on 9 September 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条